ESR2 and breast carcinoma: Similarly, investigations into estrogen receptor beta (ERβ, encoded by ESR2) in breast cancer have revealed its association with improved overall survival and immune response modulation, suggesting that high ESR2 expression, particularly in basal‐ and normal‐like subtypes, may correlate with favorable prognosis.2